213 related articles for article (PubMed ID: 30973841)
1. Value of fluorine-18-fluorodeoxyglucose PET/CT in localizing the primary lesion in adrenocorticotropic hormone-dependent Cushing syndrome.
Zhou J; Ju H; Zhu L; Pan Y; Lv J; Zhang Y
Nucl Med Commun; 2019 May; 40(5):539-544. PubMed ID: 30973841
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppression for
Kim K; Kim DK; Moon JH; Kim EH; Kim SH; Ku CR; Lee EJ
Cancer Imaging; 2023 Sep; 23(1):85. PubMed ID: 37700359
[TBL] [Abstract][Full Text] [Related]
3. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic efficacy of
Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
[TBL] [Abstract][Full Text] [Related]
5. New types of localization methods for adrenocorticotropic hormone-dependent Cushing's syndrome.
Senanayake R; Gillett D; MacFarlane J; Van de Meulen M; Powlson A; Koulouri O; Casey R; Bashari W; Gurnell M
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101513. PubMed ID: 34045044
[TBL] [Abstract][Full Text] [Related]
6. ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.
Sathyakumar S; Paul TV; Asha HS; Gnanamuthu BR; Paul MJ; Abraham DT; Rajaratnam S; Thomas N
Endocr Pract; 2017 Aug; 23(8):907-914. PubMed ID: 28614007
[TBL] [Abstract][Full Text] [Related]
7. Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing's Syndrome.
Serban AL; Rosso L; Mendogni P; Cremaschi A; Indirli R; Mantovani B; Rumi M; Castellani M; Chiti A; Croci GA; Mantovani G; Nosotti M; Ferrante E; Arosio M
Front Endocrinol (Lausanne); 2021; 12():687539. PubMed ID: 34305814
[TBL] [Abstract][Full Text] [Related]
8. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome.
Pacak K; Ilias I; Chen CC; Carrasquillo JA; Whatley M; Nieman LK
J Clin Endocrinol Metab; 2004 May; 89(5):2214-21. PubMed ID: 15126544
[TBL] [Abstract][Full Text] [Related]
9. The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors.
Xu H; Zhang M; Zhai G; Zhang M; Ning G; Li B
Endocrine; 2009 Dec; 36(3):385-91. PubMed ID: 19806477
[TBL] [Abstract][Full Text] [Related]
10. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
[TBL] [Abstract][Full Text] [Related]
11. Ectopic ACTH-secreting syndrome: a single-center experience.
Kakade HR; Kasaliwal R; Jagtap VS; Bukan A; Budyal SR; Khare S; Lila AR; Bandgar T; Menon PS; Shah NS
Endocr Pract; 2013; 19(6):1007-14. PubMed ID: 24013993
[TBL] [Abstract][Full Text] [Related]
12. Use of
Hou G; Jiang Y; Li F; Cheng X
Front Oncol; 2021; 11():762327. PubMed ID: 34692551
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of
Liu Q; Zang J; Yang Y; Ling Q; Wu H; Wang P; Lu L; Zhu Z
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4386-4395. PubMed ID: 34146130
[TBL] [Abstract][Full Text] [Related]
14. Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT.
Papadakis GZ; Bagci U; Sadowski SM; Patronas NJ; Stratakis CA
Clin Nucl Med; 2015 Jul; 40(7):576-8. PubMed ID: 26018709
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of 68 Ga-Pentixafor PET/CT on Diagnosis and Management of Cushing Syndrome.
Ding J; Tong A; Hacker M; Feng M; Huo L; Li X
Clin Nucl Med; 2022 Aug; 47(8):669-676. PubMed ID: 35452014
[TBL] [Abstract][Full Text] [Related]
16. Appendiceal Neuroendocrine Tumor Is a Rare Cause of Ectopic Adrenocorticotropic Hormone Syndrome With Cyclic Hypercortisolism: A Case Report and Literature Review.
Zhao YX; Ma WL; Jiang Y; Zhang GN; Wang LJ; Gong FY; Zhu HJ; Lu L
Front Endocrinol (Lausanne); 2022; 13():808199. PubMed ID: 35250866
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Strategy and Prognostic Factors for Ectopic Adrenocorticotropic Hormone Syndrome: A Retrospective Study of 64 Cases.
Chen W; Chen L; Pei L; Zeng R; Wu L; Wang C; Li Y; Xiao H; Cao X
Neuroendocrinology; 2023; 113(1):92-102. PubMed ID: 35882186
[TBL] [Abstract][Full Text] [Related]
20. PITUITARY MRI FINDINGS IN PATIENTS WITH PITUITARY AND ECTOPIC ACTH-DEPENDENT CUSHING SYNDROME: DOES A 6-MM PITUITARY TUMOR SIZE CUT-OFF VALUE EXCLUDE ECTOPIC ACTH SYNDROME?
Yogi-Morren D; Habra MA; Faiman C; Bena J; Hatipoglu B; Kennedy L; Weil RJ; Hamrahian AH
Endocr Pract; 2015 Oct; 21(10):1098-103. PubMed ID: 26121435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
